Biblio
Found 2636 results
Author [ Keyword] Title Type Year Filters: First Letter Of Last Name is R [Clear All Filters]
“Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms.”, Nature, vol. 429, no. 6987, pp. 75-9, 2004.
, “HAMR: high-throughput annotation of modified ribonucleotides.”, RNA, vol. 19, no. 12, pp. 1684-92, 2013.
, “HAMR: high-throughput annotation of modified ribonucleotides.”, RNA, vol. 19, no. 12, pp. 1684-92, 2013.
, “CoRAL: predicting non-coding RNAs from small RNA-sequencing data.”, Nucleic Acids Res, vol. 41, no. 14, p. e137, 2013.
, “Using machine learning and high-throughput RNA sequencing to classify the precursors of small non-coding RNAs.”, Methods, vol. 67, no. 1, pp. 28-35, 2014.
, “Transcriptomic Changes Due to Cytoplasmic TDP-43 Expression Reveal Dysregulation of Histone Transcripts and Nuclear Chromatin.”, PLoS One, vol. 10, no. 10, p. e0141836, 2015.
, “HAMR: high-throughput annotation of modified ribonucleotides.”, RNA, vol. 19, no. 12, pp. 1684-92, 2013.
, “Using machine learning and high-throughput RNA sequencing to classify the precursors of small non-coding RNAs.”, Methods, vol. 67, no. 1, pp. 28-35, 2014.
, “HAMR: high-throughput annotation of modified ribonucleotides.”, RNA, vol. 19, no. 12, pp. 1684-92, 2013.
, “Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.”, PLoS Genet, vol. 8, no. 6, p. e1002707, 2012.
, “Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.”, JAMA Psychiatry, vol. 72, no. 5, pp. 490-9, 2015.
, “An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy.”, PLoS Genet, vol. 10, no. 3, p. e1004211, 2014.
, “Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).”, Transl Psychiatry, vol. 3, p. e256, 2013.
, “GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.”, Neuron, vol. 54, no. 5, pp. 713-20, 2007.
, “Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).”, Transl Psychiatry, vol. 3, p. e256, 2013.
, “GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.”, Neuron, vol. 54, no. 5, pp. 713-20, 2007.
, “Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).”, Transl Psychiatry, vol. 3, p. e256, 2013.
, “Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.”, Circulation, vol. 131, no. 23, pp. 2061-2069, 2015.
, “GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.”, Neuron, vol. 54, no. 5, pp. 713-20, 2007.
, “Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.”, Circulation, vol. 131, no. 23, pp. 2061-2069, 2015.
, “GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.”, Neuron, vol. 54, no. 5, pp. 713-20, 2007.
, “Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses.”, Alzheimers Dement, vol. 11, no. 12, pp. 1439-1451, 2015.
, “Analysis of European mitochondrial haplogroups with Alzheimer disease risk.”, Neurosci Lett, vol. 365, no. 1, pp. 28-32, 2004.
, “Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.”, JAMA Neurol, vol. 71, no. 11, pp. 1394-404, 2014.
, “Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.”, JAMA Neurol, vol. 71, no. 11, pp. 1394-404, 2014.
,